DOD Credit Office Signs $80M Loan for Domestic Biomanufacturing
8 Articles
8 Articles
DOD credit office signs $80M loan for domestic biomanufacturing
The Defense Department's credit office signed a conditional loan agreement with pharmaceutical manufacturer Antheia Inc. over the weekend to support and expand the company's domestic production of key starting materials and active pharmaceutical ingredients using bioengineered yeast. “Antheia’s biosynthesis platform represents an innovative method to establish cost-effective domestic supply chains which enable the United States to compete global…
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...
Antheia reported that the US Department of War's Strategic Capital Office offered her a conditional direct loan commitment of up to $80 million to expand her domestic manufacture of critical pharmaceutical ingredients.
US backs $80 million drug supply project
Washington, Oct 18 (SocialNews.XYZ) The US Department of War announced an $80 million conditional loan commitment to biotechnology company Antheia to expand domestic production of essential pharmaceutical ingredients, as the Trump administration seeks to reduce... - Social News XYZ
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






